JP2014517954A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014517954A5 JP2014517954A5 JP2014505670A JP2014505670A JP2014517954A5 JP 2014517954 A5 JP2014517954 A5 JP 2014517954A5 JP 2014505670 A JP2014505670 A JP 2014505670A JP 2014505670 A JP2014505670 A JP 2014505670A JP 2014517954 A5 JP2014517954 A5 JP 2014517954A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- cluster
- intensity
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 40
- 210000001519 tissue Anatomy 0.000 claims 13
- 239000012528 membrane Substances 0.000 claims 11
- 201000010099 disease Diseases 0.000 claims 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 10
- 239000000090 biomarker Substances 0.000 claims 9
- 210000000805 cytoplasm Anatomy 0.000 claims 9
- 238000000034 method Methods 0.000 claims 7
- 238000004393 prognosis Methods 0.000 claims 7
- 238000003745 diagnosis Methods 0.000 claims 6
- 102000015735 Beta-catenin Human genes 0.000 claims 5
- 108060000903 Beta-catenin Proteins 0.000 claims 5
- 238000011156 evaluation Methods 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 230000036210 malignancy Effects 0.000 claims 3
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 claims 2
- 102100036360 Cadherin-3 Human genes 0.000 claims 2
- 101000714553 Homo sapiens Cadherin-3 Proteins 0.000 claims 2
- 102000011782 Keratins Human genes 0.000 claims 2
- 108010076876 Keratins Proteins 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 230000001413 cellular effect Effects 0.000 claims 2
- 230000001086 cytosolic effect Effects 0.000 claims 2
- 238000009877 rendering Methods 0.000 claims 2
- 230000004083 survival effect Effects 0.000 claims 2
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161478224P | 2011-04-22 | 2011-04-22 | |
| US61/478,224 | 2011-04-22 | ||
| US13/252,078 | 2011-10-03 | ||
| US13/252,080 US20120271553A1 (en) | 2011-04-22 | 2011-10-03 | Analyzing the expression of biomarkers in cells with clusters |
| US13/252,080 | 2011-10-03 | ||
| US13/252,069 US20120270752A1 (en) | 2011-04-22 | 2011-10-03 | Analyzing the expression of biomarkers in cells with moments |
| US13/252,072 US20120269418A1 (en) | 2011-04-22 | 2011-10-03 | Analyzing the expression of biomarkers in cells with clusters |
| US13/252,072 | 2011-10-03 | ||
| US13/252,069 | 2011-10-03 | ||
| US13/252,078 US20120269419A1 (en) | 2011-04-22 | 2011-10-03 | Analyzing the expression of biomarkers in cells with moments |
| PCT/EP2012/057394 WO2012143561A2 (en) | 2011-04-22 | 2012-04-23 | Analyzing the expression of biomarkers in cells with clusters |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014517954A JP2014517954A (ja) | 2014-07-24 |
| JP2014517954A5 true JP2014517954A5 (https=) | 2015-06-18 |
| JP6143743B2 JP6143743B2 (ja) | 2017-06-07 |
Family
ID=47021377
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014505670A Active JP6143743B2 (ja) | 2011-04-22 | 2012-04-23 | 細胞におけるバイオマーカーの発現のクラスターによる解析 |
| JP2014505669A Active JP6063446B2 (ja) | 2011-04-22 | 2012-04-23 | 細胞におけるバイオマーカーの発現の積率による解析 |
| JP2014505668A Active JP6163152B2 (ja) | 2011-04-22 | 2012-04-23 | 細胞におけるバイオマーカーの発現の積率による解析 |
| JP2014505671A Active JP6063447B2 (ja) | 2011-04-22 | 2012-04-23 | 細胞におけるバイオマーカーの発現のクラスターによる解析 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014505669A Active JP6063446B2 (ja) | 2011-04-22 | 2012-04-23 | 細胞におけるバイオマーカーの発現の積率による解析 |
| JP2014505668A Active JP6163152B2 (ja) | 2011-04-22 | 2012-04-23 | 細胞におけるバイオマーカーの発現の積率による解析 |
| JP2014505671A Active JP6063447B2 (ja) | 2011-04-22 | 2012-04-23 | 細胞におけるバイオマーカーの発現のクラスターによる解析 |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US20120269419A1 (https=) |
| EP (4) | EP2700042B1 (https=) |
| JP (4) | JP6143743B2 (https=) |
| BR (4) | BR112013027122A2 (https=) |
| CA (4) | CA2833804A1 (https=) |
| RU (3) | RU2013145162A (https=) |
| SG (4) | SG194588A1 (https=) |
| WO (4) | WO2012143558A2 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201111594D0 (en) * | 2011-07-06 | 2011-08-24 | Equateq Ltd | New improved process |
| EP2929420B1 (en) * | 2012-12-06 | 2022-03-02 | Leica Microsystems CMS GmbH | Systems and methods for split screen display of a biological specimen and for capturing records thereof |
| US9488639B2 (en) * | 2013-02-25 | 2016-11-08 | Flagship Biosciences, Inc. | Cell-based tissue analysis |
| US8995740B2 (en) * | 2013-04-17 | 2015-03-31 | General Electric Company | System and method for multiplexed biomarker quantitation using single cell segmentation on sequentially stained tissue |
| CA2916520A1 (en) * | 2013-07-03 | 2015-01-08 | Coyne Ip Holdings, Llc | Methods for predicting responses to chemical or biologic substances |
| US9322051B2 (en) | 2013-10-07 | 2016-04-26 | General Electric Company | Probing of biological samples |
| US9298968B1 (en) * | 2014-09-12 | 2016-03-29 | Flagship Biosciences, Inc. | Digital image analysis of inflammatory cells and mediators of inflammation |
| JP6791598B2 (ja) | 2015-01-22 | 2020-11-25 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 異なる細胞サブセットの比率の決定方法およびシステム |
| US9953133B2 (en) | 2015-06-03 | 2018-04-24 | General Electric Company | Biological data annotation and visualization |
| US10672505B2 (en) | 2015-06-03 | 2020-06-02 | General Electric Company | Biological data annotation and visualization |
| WO2017109860A1 (ja) * | 2015-12-22 | 2017-06-29 | 株式会社ニコン | 画像処理装置 |
| US20180032681A1 (en) * | 2016-07-29 | 2018-02-01 | General Electric Company | Biological feature analysis technique |
| CN110192140A (zh) * | 2016-11-16 | 2019-08-30 | 华盛顿大学 | 用于循环荧光成像的系统和方法 |
| US11042551B2 (en) * | 2016-12-02 | 2021-06-22 | Fair Isaac Corporation | Fast automatic explanation of scored observations |
| US11436719B2 (en) | 2017-02-16 | 2022-09-06 | Kyoto University | Cell evaluation method, cell evaluation device, and recording medium storing cell evaluation program |
| US10242473B2 (en) * | 2017-03-22 | 2019-03-26 | Sas Institute Inc. | Computer system to generate scalable plots using clustering |
| US10535434B2 (en) | 2017-04-28 | 2020-01-14 | 4D Path Inc. | Apparatus, systems, and methods for rapid cancer detection |
| KR101990430B1 (ko) * | 2017-06-22 | 2019-06-18 | 한국과학기술원 | 암의 재발 예후 예측을 위한 바이오마커 발굴 시스템 및 방법 |
| US12249401B2 (en) | 2017-07-21 | 2025-03-11 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for analyzing mixed cell populations |
| US10706328B2 (en) | 2018-05-07 | 2020-07-07 | Google Llc | Focus-weighted, machine learning disease classifier error prediction for microscope slide images |
| US10971255B2 (en) * | 2018-09-14 | 2021-04-06 | Zasti Inc. | Multimodal learning framework for analysis of clinical trials |
| US11101043B2 (en) | 2018-09-24 | 2021-08-24 | Zasti Inc. | Hybrid analysis framework for prediction of outcomes in clinical trials |
| US20220015714A1 (en) * | 2018-11-29 | 2022-01-20 | Somalogic, Inc. | Methods For Determining Disease Risk Combining Downsampling of Class-Imbalanced Sets With Survival Analysis |
| US11128667B2 (en) * | 2018-11-29 | 2021-09-21 | Rapid7, Inc. | Cluster detection and elimination in security environments |
| CN113158982A (zh) * | 2021-05-17 | 2021-07-23 | 广东中卡云计算有限公司 | 一种半介入式的目标关键点标注方法 |
| WO2023033056A1 (ja) * | 2021-09-01 | 2023-03-09 | イミュニティリサーチ株式会社 | 細胞集団同定システム、方法、およびプログラム |
| IT202200001817A1 (it) | 2022-02-02 | 2023-08-02 | Aizoon S R L | Procedimento per la prognosi di una malattia in seguito ad un trattamento terapeutico, relativo sistema e prodotto informatico |
| IT202200005861A1 (it) | 2022-03-24 | 2023-09-24 | Aizoon S R L | Procedimento per stimare una variabile di interesse associata ad una data malattia in funzione di una pluralità di diversi dati omici, relativo dispositivo e prodotto informatico |
| CA3207405A1 (en) | 2022-07-25 | 2024-01-25 | Aizoon S.r.l. | Method for providing a clinical decision support, corresponding system for providing a clinical decision support, and computer program product |
| WO2025258375A1 (ja) * | 2024-06-12 | 2025-12-18 | ソニーグループ株式会社 | 情報処理方法及び情報処理システム |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6463438B1 (en) * | 1994-06-03 | 2002-10-08 | Urocor, Inc. | Neural network for cell image analysis for identification of abnormal cells |
| US5740269A (en) * | 1994-09-20 | 1998-04-14 | Neopath, Inc. | Method and apparatus for robust biological specimen classification |
| US6996549B2 (en) * | 1998-05-01 | 2006-02-07 | Health Discovery Corporation | Computer-aided image analysis |
| US6282305B1 (en) * | 1998-06-05 | 2001-08-28 | Arch Development Corporation | Method and system for the computerized assessment of breast cancer risk |
| US6337472B1 (en) * | 1998-10-19 | 2002-01-08 | The University Of Texas System Board Of Regents | Light imaging microscope having spatially resolved images |
| JP2005503760A (ja) * | 2001-01-24 | 2005-02-10 | プロテイン デザイン ラブス， インコーポレイテッド | 乳癌の診断方法、組成物および乳癌のモジュレーターのスクリーニング方法 |
| WO2004013658A2 (en) * | 2002-07-30 | 2004-02-12 | Deutsches Krebsforschungszentrum | Method and apparatus for multiple labeling detection and evaluation of a plurality of particles |
| US20040121413A1 (en) * | 2002-12-20 | 2004-06-24 | Aebersold Rudolf H. | Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions |
| US20050265588A1 (en) * | 2004-02-03 | 2005-12-01 | Bioimagene, Inc. | Method and system for digital image based flourescent in situ hybridization (FISH) analysis |
| WO2006113747A2 (en) * | 2005-04-19 | 2006-10-26 | Prediction Sciences Llc | Diagnostic markers of breast cancer treatment and progression and methods of use thereof |
| US8041090B2 (en) * | 2005-09-10 | 2011-10-18 | Ge Healthcare Uk Limited | Method of, and apparatus and computer software for, performing image processing |
| US7933435B2 (en) * | 2005-11-21 | 2011-04-26 | Vala Sciences, Inc. | System, method, and kit for processing a magnified image of biological material to identify components of a biological object |
| CN101484806A (zh) * | 2006-05-17 | 2009-07-15 | 协乐民公司 | 一种对组织进行自动分析的方法 |
| US7741045B2 (en) * | 2006-11-16 | 2010-06-22 | General Electric Company | Sequential analysis of biological samples |
| US8019134B2 (en) * | 2006-11-16 | 2011-09-13 | Definiens Ag | Automatic image analysis and quantification for fluorescence in situ hybridization |
| EP2132327A2 (en) * | 2007-03-27 | 2009-12-16 | Rosetta Genomics Ltd | Gene expression signature for classification of cancers |
| CA2683134A1 (en) * | 2007-05-07 | 2008-11-13 | Ge Healthcare Bio-Sciences Corp. | System and method for the automated analysis of cellular assays and tissues |
| WO2008143849A2 (en) * | 2007-05-14 | 2008-11-27 | Historx, Inc. | Compartment segregation by pixel characterization using image data clustering |
| EP2195467B1 (en) * | 2007-09-06 | 2016-12-14 | bioTheranostics, Inc. | Tumor grading and cancer prognosis in breast cancer |
| US9858389B2 (en) * | 2008-07-25 | 2018-01-02 | Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud | Method and system for determining the risk of occurrence of prostate cancer |
| US9779213B2 (en) * | 2008-07-25 | 2017-10-03 | Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud | System for evaluating a pathological stage of prostate cancer |
| US8320655B2 (en) * | 2009-10-16 | 2012-11-27 | General Electric Company | Process and system for analyzing the expression of biomarkers in cells |
| US20110091081A1 (en) * | 2009-10-16 | 2011-04-21 | General Electric Company | Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin |
| WO2011087778A1 (en) * | 2009-12-22 | 2011-07-21 | The Children's Hospital Of Philadelphia | Automated quantitative multidimensional volumetric analysis and visualization |
-
2011
- 2011-10-03 US US13/252,078 patent/US20120269419A1/en not_active Abandoned
- 2011-10-03 US US13/252,069 patent/US20120270752A1/en not_active Abandoned
- 2011-10-03 US US13/252,080 patent/US20120271553A1/en not_active Abandoned
- 2011-10-03 US US13/252,072 patent/US20120269418A1/en not_active Abandoned
-
2012
- 2012-04-23 BR BR112013027122A patent/BR112013027122A2/pt not_active IP Right Cessation
- 2012-04-23 WO PCT/EP2012/057390 patent/WO2012143558A2/en not_active Ceased
- 2012-04-23 JP JP2014505670A patent/JP6143743B2/ja active Active
- 2012-04-23 WO PCT/EP2012/057394 patent/WO2012143561A2/en not_active Ceased
- 2012-04-23 RU RU2013145162/15A patent/RU2013145162A/ru not_active Application Discontinuation
- 2012-04-23 JP JP2014505669A patent/JP6063446B2/ja active Active
- 2012-04-23 BR BR112013027124A patent/BR112013027124A2/pt not_active IP Right Cessation
- 2012-04-23 SG SG2013078688A patent/SG194588A1/en unknown
- 2012-04-23 BR BR112013027123A patent/BR112013027123A2/pt not_active IP Right Cessation
- 2012-04-23 CA CA2833804A patent/CA2833804A1/en not_active Abandoned
- 2012-04-23 CA CA2833428A patent/CA2833428A1/en not_active Abandoned
- 2012-04-23 BR BR112013027125A patent/BR112013027125A2/pt not_active IP Right Cessation
- 2012-04-23 EP EP12719316.7A patent/EP2700042B1/en active Active
- 2012-04-23 SG SG2013078738A patent/SG194592A1/en unknown
- 2012-04-23 SG SG2013078753A patent/SG194594A1/en unknown
- 2012-04-23 RU RU2013145151/15A patent/RU2013145151A/ru not_active Application Discontinuation
- 2012-04-23 CA CA2833295A patent/CA2833295A1/en not_active Abandoned
- 2012-04-23 WO PCT/EP2012/057387 patent/WO2012143556A2/en not_active Ceased
- 2012-04-23 EP EP12716028.1A patent/EP2700037A2/en not_active Withdrawn
- 2012-04-23 JP JP2014505668A patent/JP6163152B2/ja active Active
- 2012-04-23 JP JP2014505671A patent/JP6063447B2/ja active Active
- 2012-04-23 CA CA2833497A patent/CA2833497A1/en not_active Abandoned
- 2012-04-23 EP EP12716027.3A patent/EP2700036A2/en not_active Withdrawn
- 2012-04-23 WO PCT/EP2012/057395 patent/WO2012143562A2/en not_active Ceased
- 2012-04-23 SG SG2013078712A patent/SG194590A1/en unknown
- 2012-04-23 EP EP12717662.6A patent/EP2700038B1/en active Active
- 2012-04-23 RU RU2013145154/15A patent/RU2013145154A/ru not_active Application Discontinuation
-
2014
- 2014-03-05 US US14/197,558 patent/US20140185905A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014517954A5 (https=) | ||
| RU2013145154A (ru) | Анализ экспрессии биомаркеров в клетках с помощью кластеров | |
| Alabi et al. | Comparison of supervised machine learning classification techniques in prediction of locoregional recurrences in early oral tongue cancer | |
| Deutsch et al. | Trans‐Proteomic Pipeline, a standardized data processing pipeline for large‐scale reproducible proteomics informatics | |
| JP2014521925A5 (https=) | ||
| Yang et al. | Prediction of prognosis and treatment response in ovarian cancer patients from histopathology images using graph deep learning: a multicenter retrospective study | |
| JP2014516413A5 (https=) | ||
| Morse et al. | Reliable identification of prostate cancer using mass spectrometry metabolomic imaging in needle core biopsies | |
| O'Shea et al. | Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study | |
| AU2015357091A1 (en) | Systems and methods for early-stage cancer prognosis | |
| US20150185204A1 (en) | Circulating tumor cell diagnostics for lung cancer | |
| KR102044094B1 (ko) | 딥 러닝 기반 유전체 발현량 해석을 통한 암 또는 정상 판별 방법 및 그 장치 | |
| MX2020009705A (es) | Metodos para la deteccion del riesgo de enfermedad renal cronica en un sujeto y metodo implementado por computadora. | |
| JP2015518152A (ja) | 前立腺がんの検出用バイオマーカーの定量 | |
| WO2009102729A1 (en) | Association of biomarkers with patient outcome | |
| Zhao et al. | Multiplex imaging in immuno-oncology | |
| EP4150633A1 (en) | Single-cell morphology analysis for disease profiling and drug discovery | |
| CN121359210A (zh) | 用于早期癌症检测和亚型分型的系统和方法 | |
| Xin et al. | Integrative radiomics analyses identify universal signature for predicting prognosis and therapeutic vulnerabilities across primary and secondary liver cancers: a multi-cohort study | |
| CN120298369A (zh) | 用于预测肝癌超进展的多模态影像模型训练方法及装置 | |
| CA2890898A1 (en) | Metabolic profiling in tissue and serum is indicative of tumor differentiation in prostate cancer | |
| Vaida et al. | Identifying Robust Biomarker Panels for Breast Cancer Screening | |
| Wu et al. | A deep learning-based multimodal clinico-histology-genomic prognostic model in prostate cancer | |
| US20250022603A1 (en) | Predicting progression of cognitive impairment | |
| CN121904534A (zh) | 基于力学检测的tls评估预测方法及系统 |